- mab: Adintrevimab
  synonyms: ADG20;ADG-2
  num_ref_name: 33
  num_fold: 253
  avail: Phase 3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7U2D
  institute: Adagio Therapeutics
  origin: CP
- mab: C144
  synonyms: BMS-986413
  num_ref_name: 16
  num_fold: 175
  avail: Phase 2/3
  target: RBD
  class: RBM Class III
  pdb: 7K90
  institute: Rockefeller University
  origin: CP
- mab: C135
  synonyms: BMS-986414
  num_ref_name: 12
  num_fold: 115
  avail: Phase 2/3
  target: RBD
  class: RBD Core Cluster I
  pdb: 7K8Z
  institute: Rockefeller University
  origin: CP
- mab: STI-2020
  synonyms: COVI-AMG
  num_ref_name: 1
  num_fold: 1
  avail: Phase 2
  target: ''
  class: ''
  pdb: ''
  institute: Sorrento Therapeutics
  origin: Phage display library
- mab: ABBV-47D11
  synonyms: 47D11
  num_ref_name: 4
  num_fold: 30
  avail: Phase 1
  target: RBD
  class: RBD Core Cluster I
  pdb: 7AKD
  institute: Utrecht University & AbbVie
  origin: Transgenic mice
- mab: Regdanvimab
  synonyms: CT-P59
  num_ref_name: 25
  num_fold: 169
  avail: KR-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CM4
  institute: Celltrion
  origin: Phage display library
- mab: Sotrovimab
  synonyms: GSK4182136;S309;Vir-7831;Xevudy
  num_ref_name: 106
  num_fold: 1118
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6WPS
  institute: Vir Biotechnol
  origin: SARS-CoV CP
- mab: Imdevimab
  synonyms: REGN10987
  num_ref_name: 110
  num_fold: 968
  avail: EUA
  target: RBD
  class: RBD Core Cluster I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Casirivimab
  synonyms: REGN10933
  num_ref_name: 107
  num_fold: 920
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 6XDG
  institute: Regeneron
  origin: Transgenic mice
- mab: Cilgavimab
  synonyms: COV2-2130;AZD1061
  num_ref_name: 87
  num_fold: 771
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Bebtelovimab
  synonyms: LY-CoV1404;LY3853113
  num_ref_name: 49
  num_fold: 764
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7MMO
  institute: Eli Lilly
  origin: CP
- mab: Etesevimab
  synonyms: CB6;Shi-CB6;JS-016;LY-CoV016;LY3832479
  num_ref_name: 81
  num_fold: 731
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7C01
  institute: Eli Lilly
  origin: CP
- mab: Tixagevimab
  synonyms: COV2-2196;AZD8895
  num_ref_name: 82
  num_fold: 650
  avail: EUA
  target: RBD
  class: RBM Class I
  pdb: 7L7E
  institute: AstraZeneca
  origin: CP
- mab: Bamlanivimab
  synonyms: LY-CoV555;LY3819253
  num_ref_name: 77
  num_fold: 598
  avail: EUA
  target: RBD
  class: RBM Class II
  pdb: 7KMG
  institute: Eli Lilly
  origin: CP
- mab: Amubarvimab
  synonyms: BRII-196;P2C-1F11
  num_ref_name: 30
  num_fold: 468
  avail: CN-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CDI
  institute: Brii Biosciences
  origin: ''
- mab: Romlusevimab
  synonyms: BRII-198;P2B-1G5
  num_ref_name: 18
  num_fold: 247
  avail: CN-Approved
  target: RBD
  class: RBD Core Cluster II
  pdb: ''
  institute: Brii Biosciences
  origin: ''
- mab: DXP-604
  synonyms: BD-604
  num_ref_name: 7
  num_fold: 126
  avail: CN-Approved
  target: RBD
  class: RBM Class I
  pdb: 7CH4
  institute: Singlomics Biopharmaceuticals
  origin: CP
